Policy and Advocacy | Canteen Australia

Our policy advocacy work aims to influence governments and other stakeholders to ensure they prioritise the needs of young people and their families who have been impacted by cancer. We advocate in local, national and international arenas, build powerful partnerships and empower young people to stand up and be heard.

What is policy and advocacy?

Block Content

Policy

What to influence

Broad statement of goals, objectives and means that create the framework for activity.

Advocacy

How to influence

Action taken in support of a particular policy or cause.

Objectives

Improve access to quality healthcare services for young cancer patients and survivors.
Enhance psychosocial support programs and resources.
Promote educational and employment opportunities for young people affected by cancer.
Reduce disparities and ensuring equitable access to care and support.

Latest news

Australian Cancer Plan

young person with cancer using canteen's robots service in hospital

The launch of the new Australian Cancer Plan

The launch of the new Australian Cancer Plan (the Plan) yesterday is an exciting milestone for cancer care in Australia. This is a once in a generation opportunity to improve experiences and outcomes for people affected by cancer.

Tackling the financial costs of cancer

young person impacted by cancer leaning on a window

We are lucky to have a world class public health system in Australia where people can access free and subsidised medi

The hidden costs of cancer can be particularly difficult for young people and can have long-term implications.

Launch of AYA Vision 2033

We are excited to introduce AYA Vision 2033, a cancer plan for Australian adolescent and young adult (AYA) patients.

Latest submissions

Policy and Advocacy

Health Technology Assessment - Collaborative Consumer Group Response

This submission focuses on the collaborative consumer group response to the Health Technology Assessment review.

Policy and Advocacy

Health Technology Assessment Policy and Methods Review

This submission is regarding the policy and methods for assessment of cancer medicines by the Pharmaceutical Benefits Advisory Committee (PBAC).

Policy and Advocacy

MSAC review of Tisagenlecleucel, 2023

MSAC Review of Tisagenlecleucel for treatment of confirmed relapsed/refractory CD19-positive acute lymphoblastic leukaemia in children & young adults up to 25 years old.

Latest reports

AYA Vision 2023 screenshot of front page

Policy and Advocacy

AYA Vision 2033

For adolescents and young adults with cancer

Policy and Advocacy

Making an impact: social return on investment

To enable us to realise our true impact, Canteen worked in collaboration with Deloitte to measure the value of the programs Canteen delivers for young people through a Social Impact Analysis.

Policy and Advocacy

Strategic plan 2021-26

Canteen will operate across four strategic pillars to ensure that young people and their families get the best possible support to cope with the immense challenges of cancer.

Find out more